Literature DB >> 20798531

Gender-specific reduction in contraction is associated with increased estrogen receptor expression in single vascular smooth muscle cells of female rat.

Yukui Ma1, Xiaoying Qiao, Anthony E Falone, Ossama M Reslan, Stephanie J Sheppard, Raouf A Khalil.   

Abstract

Gender differences in the incidence of cardiovascular disease have been related to plasma estrogen levels; however, the role of vascular estrogen receptor (ER) subtypes in these sex differences is less clear. We tested whether the gender differences in vascular smooth muscle (VSM) function reflect differential expression/activity of ERalpha, ERbeta and the newly-identified GPR30. Single aortic VSM cells (VSMCs) were freshly isolated from male and female Sprague-Dawley rats, and their contraction to phenylephrine (PHE, 10(-5) M), AngII (10(-7) M) and membrane-depolarization by KCl (51 mM) was measured in the absence or presence of 10(-6) M 17beta-estradiol (E2, stimulant of most ERs), PPT (ERalpha agonist), DPN (ERbeta agonist), and ICI 182,780 (an ERalpha/ERbeta antagonist with GPR30 agonistic properties). The cells were fixed and fluorescently labeled with ERalpha, ERbeta or GPR30 antibody, and the subcellular distribution of ERs was examined using digital imaging microscopy. The mRNA expression and protein amount of aortic ER subtypes was examined using RT-PCR and Western blots. PHE, AngII, and KCl caused less contraction in VSMCs of females than males. Pretreatment of VSMCs with E2 reduced PHE-, AngII- and KCl-induced contraction in both males and females. PPT caused similar inhibition of PHE-, AngII- and KCl-induced contraction as E2, suggesting a role of ERalpha. DPN mainly inhibited PHE and KCl contraction, suggesting an interaction between ERbeta and Ca(2+) channels. ICI 182,780 did not reduce aortic VSMC contraction, suggesting little role for GPR30. RT-PCR and Western blots revealed greater expression of ERalpha and ERbeta in VSMCs of females than males, but similar amounts of GPR30. The total immunofluorescence signal for ERalpha and ERbeta was greater in VSMCs of females than males, and was largely localized in the nucleus. GPR30 fluorescence was similar in VSMCs of males and females, and was mainly in the cytosol. In PPT treated cells, nuclear ERalpha signal was enhanced. DPN did not affect the distribution of ERbeta, and ICI 182,780 did not significantly increase GPR30 in the cell surface. Thus, ER subtypes demonstrate similar responsiveness to specific agonists in VSMCs of male and female rats. The reduced contraction in VSMCs of females could be due to gender-related increase in the expression of ERalpha and ERbeta. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798531      PMCID: PMC2929922          DOI: 10.1159/000320569

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  66 in total

Review 1.  Signal transduction mechanisms of the angiotensin II type AT(1)-receptor: looking beyond the heterotrimeric G protein paradigm.

Authors:  P P Sayeski; K E Bernstein
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-03       Impact factor: 1.636

2.  Epitope-dependent localization of estrogen receptor-alpha, but not -beta, in en face arterial endothelium.

Authors:  Pauline Dan; Joyce C Y Cheung; David R L Scriven; Edwin D W Moore
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-12-12       Impact factor: 4.733

3.  Acute effects of oestrogen receptor subtype-specific agonists on vascular contractility.

Authors:  Sandra Montgomery; Linda Shaw; Nick Pantelides; Michael Taggart; Clare Austin
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 4.  Genomic and nongenomic effects of estrogen in the vasculature.

Authors:  Michael E Mendelsohn
Journal:  Am J Cardiol       Date:  2002-07-03       Impact factor: 2.778

5.  Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

Authors:  S R Stauffer; C J Coletta; R Tedesco; G Nishiguchi; K Carlson; J Sun; B S Katzenellenbogen; J A Katzenellenbogen
Journal:  J Med Chem       Date:  2000-12-28       Impact factor: 7.446

6.  Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury.

Authors:  Gary Pare; Andrée Krust; Richard H Karas; Sonia Dupont; Mark Aronovitz; Pierre Chambon; Michael E Mendelsohn
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

7.  Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta.

Authors:  Yan Zhu; Zhao Bian; Ping Lu; Richard H Karas; Lin Bao; Daniel Cox; Jeffrey Hodgin; Philip W Shaul; Peter Thoren; Oliver Smithies; Jan-Ake Gustafsson; Michael E Mendelsohn
Journal:  Science       Date:  2002-01-18       Impact factor: 47.728

8.  Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle.

Authors:  C A Kanashiro; R A Khalil
Journal:  Am J Physiol Cell Physiol       Date:  2001-01       Impact factor: 4.249

9.  Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta.

Authors:  Akira Ishihata; Katsunari Tasaki; Yumi Katano
Journal:  Eur J Pharmacol       Date:  2002-06-12       Impact factor: 4.432

10.  Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.

Authors:  William R Harrington; Shubin Sheng; Daniel H Barnett; Larry N Petz; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Cell Endocrinol       Date:  2003-08-29       Impact factor: 4.102

View more
  23 in total

Review 1.  The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Vascul Pharmacol       Date:  2011-07-05       Impact factor: 5.773

Review 2.  Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen.

Authors:  Sarah H Lindsey; Mark C Chappell
Journal:  Gend Med       Date:  2011-12

3.  Estrogen receptor beta dependent attenuation of cytokine-induced cyclooxygenase-2 by androgens in human brain vascular smooth muscle cells and rat mesenteric arteries.

Authors:  Kristen L Zuloaga; Devin T O'Connor; Robert J Handa; Rayna J Gonzales
Journal:  Steroids       Date:  2012-04-20       Impact factor: 2.668

4.  Analysis of sex hormone genes reveals gender differences in the genetic etiology of blood pressure salt sensitivity: the GenSalt study.

Authors:  Tanika N Kelly; Casey M Rebholz; Dongfeng Gu; James E Hixson; Treva K Rice; Jie Cao; Jichun Chen; Jianxin Li; Fanghong Lu; Jixiang Ma; Jianjun Mu; Paul K Whelton; Jiang He
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

5.  Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.

Authors:  Ossama M Reslan; Zongzhi Yin; Graciliano R A do Nascimento; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

6.  Resveratrol promotes endothelial cell wound healing under laminar shear stress through an estrogen receptor-α-dependent pathway.

Authors:  Arif Yurdagul; James J Kleinedler; Marshall C McInnis; Alok R Khandelwal; Allyson L Spence; A Wayne Orr; Tammy R Dugas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

7.  GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011

8.  Adaptive increases in expression and vasodilator activity of estrogen receptor subtypes in a blood vessel-specific pattern during pregnancy.

Authors:  Karina M Mata; Wei Li; Ossama M Reslan; Waleed T Siddiqui; Lauren A Opsasnick; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-25       Impact factor: 4.733

9.  Adaptive regulation of endothelin receptor type-A and type-B in vascular smooth muscle cells during pregnancy in rats.

Authors:  Minghui Ou; Yiping Dang; Marc Q Mazzuca; Rebecca Basile; Raouf A Khalil
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

10.  Testosterone and secondary hypertension: new pieces to the puzzle.

Authors:  Matthias Barton; Eric R Prossnitz; Matthias R Meyer
Journal:  Hypertension       Date:  2012-05-07       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.